Furthermore, POT1 mutations are more prevalent in CLL types with poor prognosis, in which the patients exhibit severe clinical signs, increased telomere shortening rate, and complex cytogenetics [101]. Here, POT1 is linked to B-cell chronic lymphocytic leukemia.